跳至主要内容
临床试验/IRCT138809102799N1
IRCT138809102799N1已完成未知

The effect of erythropoietin in reduction of tissue–reperfusion injury after coronary artery baypass graft

Deputy of Research and Technology of Mazandarn University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • sign of angina pectoris need to revascularization after angiography, presence of indication for CABG
  • Exclusion criteria: history of Myocardial Infarction since 3 months prior to the study, EF<30%, history of streptokinase taking, hemoglobin >16 , Cr > 2.5, receiving Erythropoietin since 6 months prior to the study, blood pressure > 150/95, history of Arterial fibrillation blood transfusion since 3 months prior to the study, heavy or cardiac trauma since 3 months prior to the study, polycytemia vera

排除标准

  • 未提供

研究者

发起方
Deputy of Research and Technology of Mazandarn University of Medical Sciences

相似试验